Login
$MBX
$53.12 -$2.82 (5.04%) Live

Company Executives

Officer Age In this role 2025 pay Source
Steven L. Hoerter Also a director
Chairman, President and CEO
Title from the Form 4 dated Nov 10, 2026
55 Not stated Not reported
John Smither
Interim Chief Financial Officer
73 Since 2026
this year
Not reported
Salomon Azoulay
Chief Medical Officer
69 Since 2024
2 years
$1,474,978

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 22, 2026 · updated by the 8-K of Oct 22, 2026

Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
3.8 years
from year joined
CEO also chairs the board
No
Steven L. Hoerter
Director Age On board Independent Committees Other public boards 2025 pay Source
Steven L. Hoerter
55 2025
1 year
Independent
Audit Committee Science and Medicine Committee
ORIC Pharmaceuticals, Inc. $999,986
P. Kent Hawryluk
57 2019
7 years
Not independent None stated None stated Paid as CEO
Patrick J. Heron
55 2020
6 years
Independent
Nominating and Corporate Governance Committee Compensation Committee · Chair
Mirum Pharmaceuticals, Inc. $220,947
Edward T. Mathers
66 2020
6 years
Independent
Nominating and Corporate Governance Committee Science and Medicine Committee
Rhythm Pharmaceuticals, Inc. $196,190
Tiba Aynechi
50 2022
4 years
Independent
Audit Committee Compensation Committee
None stated $200,690
Ora Pescovitz
69 2022
4 years
Independent
Science and Medicine Committee
None stated $198,947
Steven Ryder
75 2024
2 years
Independent None stated None stated $194,947
Laurie Stelzer
58 2026
this year
Independent
Compensation Committee
Spyre Therapeutics, Inc. Not stated
Peter Radovich Joined Oct 20, 2026
- - Independent - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 22, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support